Accumulation patterns point to a tsunami of buying late this afternoon and then either dead quiet tomorrow . . . .or RECORD one day volume for this stock. IMOSwiss
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%